Trials / Completed
CompletedNCT04637139
A Study to Evaluate the Mass Balance Absorption and AME of VBR
An Open Label Phase 1 Study in Healthy Adult Male Subjects to Determine the Mass Balance Recovery, Absorption, Metabolism, and Excretion of [14C] Vebicorvir Following Single Oral Dose Administration
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Assembly Biosciences · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This Phase 1 Study will determine the mass balance recovery, absorption, metabolism, and excretion of \[14C\] Vebicorvir in healthy male subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vebicorvir (VBR) | 300mg Vebicovir containing 2 µCi \[14C\]VBR. |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2020-12-22
- Completion
- 2020-12-22
- First posted
- 2020-11-19
- Last updated
- 2021-01-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04637139. Inclusion in this directory is not an endorsement.